英伟达向生物技术公司 Recursion 投资 5000 万美元，用于人工智能药物研发

36Kr
2023.07.12 23:09
当地时间 7 月 12 日，英伟达向生物技术公司 Recursion 投资 5000 万美元。两家公司表示，将加快该生物技术公司用于药物发现的人工智能模型的开发。Recursion 使用人工智能驱动的模型来识别和设计新的疗法，并将这些模型提供给包括罗氏、拜耳等在内的其他制药商。（新浪财经）
Source: 36Kr The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.